Menlo Park, United States
Strateos, founded in 2019 and headquartered in the United States, is a trailblazer in the creation of remote access laboratories and lab control software for the life sciences. With a mission focused on advancing the field through data and automation, their Automation-as-a-Service Platform aids researchers in designing, executing, and analyzing experiments more efficiently.
Operating at the intersection of Automation, Biotechnology, Information Technology, and Robotics, Strateos has positioned itself as a key innovator with significant potential for enhancing scientific discovery. The company's most recent capital influx was a $56.10M Series B investment received on 08 June 2021, backed by a robust lineup of investors including Lux Capital, DCVC, BDV Fund, Dolby Ventures, Eli Lilly, among others. This funding round underscores strong confidence from prominent investors in Strateos' capabilities and growth potential.
CELLINK